BioHealth News

Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

GAITHERSBURG, Md., June 26, 2025 (GLOBE NEWSWIRE) --  Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic…

Read More
Emergent Secures $62.4M Contract Boost for Botulism Antitoxin to Support U.S. Biodefense

Emergent Secures $62.4M Contract Boost for Botulism Antitoxin to Support U.S. Biodefense

GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for Strategic…

Read More
BHI and the BioHealth Capital Region Partners Showcase Our Great Assets at BIO 2025 in Boston

BHI and the BioHealth Capital Region Partners Showcase Our Great Assets at BIO 2025 in Boston

The 2025 BIO International Convention brought together over 20,000 life sciences leaders from across the globe. BioHealth Innovation, Inc. (BHI), led by Founder, President,…

Read More
VCU-born startup Evizia lands $2.2M NIH grant for commercialization of advanced DNA sequencing microscope

VCU-born startup Evizia lands $2.2M NIH grant for commercialization of advanced DNA sequencing microscope

As DNA research enters a critical stage in next-generation sequencing, better methods are needed to visualize and study molecules. Evizia, a company founded and…

Read More
Decentralizing Discovery: Lara Mangravite and the Mission of Digitalis Commons on BioTalk

Decentralizing Discovery: Lara Mangravite and the Mission of Digitalis Commons on BioTalk

In this episode of BioTalk, Lara Mangravite, PhD, Executive Director of Digitalis Commons, joins the conversation to explore how scientific research is shifting in…

Read More
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference

Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference

BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…

Read More
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference

Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference

BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…

Read More
Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

BALTIMORE--(BUSINESS WIRE)--Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Series…

Read More
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), today announced that it has entered into a binding term sheet…

Read More
ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

BALTIMORE--(BUSINESS WIRE)--ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced…

Read More
uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development

ROCKVILLE, MD / ACCESS Newswire / June 16, 2025 / uBriGene Biosciences, a leading cell and gene therapy CDMO, is proud to announce the launch of its…

Read More
NextCure and Simcere Zaiming Partner to Develop New Targeted Cancer Therapy

NextCure and Simcere Zaiming Partner to Develop New Targeted Cancer Therapy

BELTSVILLE, Md. and SHANGHAI, June 16, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat…

Read More
TEDCO Invests in Astek Diagnostics

TEDCO Invests in Astek Diagnostics

COLUMBIA, Md., (June 17, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 dual investment in Astek Diagnostics, a biomedical…

Read More
Registration Now Open for the 11th Annual BioHealth Capital Region Week

Registration Now Open for the 11th Annual BioHealth Capital Region Week

BioHealth Capital Region Week returns for its 11th year, and registration is now officially open. Scheduled for September 23–25, 2025, this annual gathering will once again take…

Read More
TEDCO Invests in Higher Medicine

TEDCO Invests in Higher Medicine

Maryland business researching treatment options for a debilitating illness COLUMBIA, Md., (June 16, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a…

Read More